Magdalena Plebanski

Prof. Dr. Magdalena Plebanski

RMIT University, Melbourne Australia
+1
orcid

Research Focus & Metrics

Academic Career Length

41Years (1986-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2004 in The Journal of Immunology
Verified
Journal Article
Closed access
PDF file
TFTheodora Fifis
Theodora Fifis
AGAnita Gamvrellis
Anita Gamvrellis
BCBlessing Crimeen-Irwin
Blessing Crimeen-Irwin
GPGeoffrey A Pietersz
Geoffrey A Pietersz
JLJie Li
Jie Li
Magdalena PlebanskiMagdalena Plebanski
Magdalena Plebanski
Infection can protect against subsequent disease by induction of both humoral and cellular immunity, but inert protein-based vaccines are not as effective. In this study, we present a new vaccine design, with Ag covalently conjugated to solid core nano-beads of narrowly defined size (0.04–0.05 μm) that localize to dendritic cells (DEC205+ CD40+, CD86+) in draining lymph nodes, inducing high levels of IFN-γ production (CD8 T cells: precursor frequencies 1/5000 to 1/1000) and high Ab titers in mice. Conjugation of Ag to these nano-beads induced responses that were significantly higher (2- to 10-fold) than those elicited by other bead sizes, and higher than a range of currently used adjuvants (alum, QuilA, monophosphoryl lipid A). Responses were comparable to CFA/IFA immunization for Abs and ex vivo peptide-pulsed dendritic cell immunization for CD8 T cells. A single dose of Ag-conjugated beads protected mice from tumors in two different model challenges and caused rapid clearance of established tumors in mice. Thus, a range of Ags conjugated to nano-beads was effective as immunogens in both therapeutic and prophylactic scenarios.

2 November 2015 in Nature Communications
Verified
Journal Article
Open access
PDF file
David J. CollinsDavid J. Collins
David J. Collins
BMBelinda Morahan
Belinda Morahan
JGJose F. Garcia-Bustos
Jose F. Garcia-Bustos
CDChristian Doerig
Christian Doerig
Magdalena PlebanskiMagdalena Plebanski
Magdalena Plebanski
ANAdrian Neild
Adrian Neild
In single-cell analysis, cellular activity and parameters are assayed on an individual, rather than population-average basis. Essential to observing the activity of these cells over time is the ability to trap, pattern and retain them, for which previous single-cell-patterning work has principally made use of mechanical methods. While successful as a long-term cell-patterning strategy, these devices remain essentially single use. Here we introduce a new method for the patterning of multiple spatially separated single particles and cells using high-frequency acoustic fields with one cell per acoustic well. We characterize and demonstrate patterning for both a range of particle sizes and the capture and patterning of cells, including human lymphocytes and red blood cells infected by the malarial parasitePlasmodium falciparum. This ability is made possible by a hitherto unexplored regime where the acoustic wavelength is on the same order as the cell dimensions.

1 September 2006 in Methods
Verified
Journal Article
Closed access
SXSue Xiang
Sue Xiang
ASAnja Scholzen
Anja Scholzen
GMGabriela Minigo
Gabriela Minigo
CDCassandra David
Cassandra David
Vasso ApostolopoulosVasso Apostolopoulos
Vasso Apostolopoulos
Magdalena PlebanskiMagdalena Plebanski
Magdalena Plebanski

6 October 2017 in Annual Review of Cell and Developmental Biology
Verified
Journal Article
Closed access
KFKatie L. Flanagan
Katie L. Flanagan
AFAshley L. Fink
Ashley L. Fink
Magdalena PlebanskiMagdalena Plebanski
Magdalena Plebanski
SKSabra L. Klein
Sabra L. Klein
Both sex (i.e., biological differences) and gender (i.e., social or cultural influences) impact vaccine acceptance, responses, and outcomes. Clinical data illustrate that among children, young adults, and aged individuals, males and females differ in vaccine-induced immune responses, adverse events, and protection. Although males are more likely to receive vaccines, following vaccination, females typically develop higher antibody responses and report more adverse effects of vaccination than do males. Human, nonhuman animal, and in vitro studies reveal numerous immunological, genetic, hormonal, and environmental factors that differ between males and females and contribute to sex- and gender-specific vaccine responses and outcomes. Herein, we address the impact of sex and gender variables that should be considered in preclinical and clinical studies of vaccines.

1 July 1999 in Nature
Verified
Journal Article
Closed access
BUBritta Christina Urban
Britta Christina Urban
DFDavid Ferguson
David Ferguson
APArnab Pain
Arnab Pain
NWNick Willcox
Nick Willcox
Magdalena PlebanskiMagdalena Plebanski
Magdalena Plebanski
DRDavid J. Roberts
David J. Roberts

7 July 2021 in Frontiers in Oncology
Verified
Journal Article
Open access
PDF file
AKApriliana E. R. Kartikasari
Apriliana E. R. Kartikasari
CHCesar S. Huertas
Cesar S. Huertas
AMArnan Mitchell
Arnan Mitchell
Magdalena PlebanskiMagdalena Plebanski
Magdalena Plebanski
Chronic inflammation generated by the tumor microenvironment is known to drive cancer initiation, proliferation, progression, metastasis, and therapeutic resistance. The tumor microenvironment promotes the secretion of diverse cytokines, in different types and stages of cancers. These cytokines may inhibit tumor development but alternatively may contribute to chronic inflammation that supports tumor growth in both autocrine and paracrine manners and have been linked to poor cancer outcomes. Such distinct sets of cytokines from the tumor microenvironment can be detected in the circulation and are thus potentially useful as biomarkers to detect cancers, predict disease outcomes and manage therapeutic choices. Indeed, analyses of circulating cytokines in combination with cancer-specific biomarkers have been proposed to simplify and improve cancer detection and prognosis, especially from minimally-invasive liquid biopsies, such as blood. Additionally, the cytokine signaling signatures of the peripheral immune cells, even from patients with localized tumors, are recently found altered in cancer, and may also prove applicable as cancer biomarkers. Here we review cytokines induced by the tumor microenvironment, their roles in various stages of cancer development, and their potential use in diagnostics and prognostics. We further discuss the established and emerging diagnostic approaches that can be used to detect cancers from liquid biopsies, and additionally the technological advancement required for their use in clinical settings.